New research suggests that certain Alzheimer’s blood biomarkers are associated with neurological symptoms of COVID-19 and older adults infected with SARS-CoV-2, the virus that…
Being Patient will speak with Dewayne Nash, a retired family physician, about his diagnosis of mild cognitive impairment due to Alzheimer’s, the lessons he…
Two first-of-their-kind studies presented at the Alzheimer’s Association International Conference show transgender and nonbinary adults are more likely show early possible signs of dementia….
In Being Patient’s LiveTalk series, scientist Ed Blonz discusses the role of glucose in maintaining brain function, and why tackling the brain’s energy deficiency…
In Being Patient’s LiveTalk series, Dr. David Weidman, associate medical director for research at the Banner Alzheimer’s Institute, shares insights on Eli Lilly’s investigational Alzheimer’s…
In Being Patient’s LiveTalk series, a scientist explores the biology of the blood-brain barrier — the brain’s layer of protection against pathogens and toxins…
Two large hospitals have decided against administering Aduhelm for patients following the FDA’s approval of the new Alzheimer’s drug in June. After the Food…